Amarin | Ativos



Assets Alterar Data
AbbVie USD 135.16B 8.26B 2024-12
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amarin USD 750.62M 49.24M 2024-09
AstraZeneca USD 106.25B 2.22B 2025-03
DBV Technologies USD 65.7M 27.36M 2024-12
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12



Amarin Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.